Standard Delivery Nationwide 🇿🇦 Shop Now
R1,100.00
In stock
Shop Online
and fill your cart
Choose Payflex at checkout
Get approved and
pay 25% today
with your debit
or credit card
Pay the remainder
over 6-weeks.
No interest.
No fees.
The world’s first overnight eye cream formulated for skin of colour. Helps with fine lines, dark circles & puffiness. Use every night for best results and discard within 2 months of first use.
Key ingredients: 0.1% Retinaldehyde, 0.1% Retinol, 2% Tranexamic acid, 1% Alpha arbutin.
Formulated for the thin, delicate skin around the eyes, at the narrow ph window, for collagen stimulation & brightening.
Dr. V Triple Action Eye Cream is non-comedogenic and ‘NAFE SAFE’ to minimise chances of irritation: No Denatured Alcohol, No Fragrance and No Essential Oils.
Warning: Not for sensitive skin or daytime use. Not to be used if pregnant, nor in conjunction with any other treatments / skincare actives. Ensure the product does not enter the eye; wash out immediately if it does.
WHY IS IT GOOD FOR SKIN OF COLOUR?
Skin of colour can suffer with both dark circles and fine lines from reduced ceramides. In addition if we are too harsh with the skin or damage is caused, it can trigger hyperpigmentation more easily.
Triple Action Eye Cream contains a delicate balance of high strength actives in a non-irritating formula and neutral ph, the perfect combination for skin of colour.
This product is ‘NAFE SAFE’ to minimise chances of irritation, with No Denatured Alcohol, No Fragrance and No Essential Oils.
WHO IS THIS PRODUCT FOR?
For persons exhibiting any of the following signs: fine lines, loose skin, puffiness, early stage dark circles.
For most skin types (normal/dry/oily/combination) & persons over 21 years and over. Not for sensitive skin.
Not for persons with a history of reactions to skincare products, dry/sensitive skin, damaged skin or if active skin conditions are present i.e. severe eczema.
Not suitable for pregnancy / breastfeeding.
 - Website by Elastic Digital
Reviews
There are no reviews yet.